Dergiler / İstanbul Kuzey Klinikleri / 2017 / Cilt: 4 - Sayı: 1

Clinical features of the patient with multiple primary tumors: Single center experience

Sayfa
43–51
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The treatment of the first tumor, smoking, squamous cell histology, and male gender were among the other factors negatively affecting survival,although they were not statistically significant.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: Multiple primary tumors are the ones that develop in the same patient at the same or different times.
📊
Temel Bulgular & Veri:If the second tumor is diagnosed 6 months after the first tumor is diagnosed, it is named as metachronous tumor.
💡
Sonuç & Katkı:The treatment of the first tumor, smoking, squamous cell histology, and male gender were among the other factors negatively affecting survival,although they were not statistically significant.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: Multiple primary tumors are the ones that develop in the same patient at the same or different times. They are usually examined under two groups. If the second tumor is diagnosed 6 months after the first tumor is diagnosed, it is named as metachronous tumor. If it is diagnosed in 6 months after the first diagnosis, it is called as synchronous tumor. The malignancy of tumors should be proved histologically. At least 2 cm of solid tissue should be present between two tumors. If they are at localized at the same place, a gap of at least 5 years should be present between them. Metastatic disease should be eliminated.This study aimedto review the clinical, demographic, and pathological features of multiple primary tumors, detect the prevalence, compare the results with literature findings, and evaluate and improve the approach to multiple primary tumors.METHODS: A total of 170 patients diagnosed with multiple primary tumors were included in this study. Patient data were obtained from pathology and medical reports of the patients.RESULTS: Most of the multiple primary tumors were metachronous. The number of male patients was more than that of female patients. The median time between double tumors was 3 monthsforsynchronous tumorsand 26 months for metachronous tumors. Synchronous tumors with the highest prevalence of comorbidity were lung-larynx and lung-colon, whereas metachronous tumors with the highest prevalence of comorbidity were lung-bladder, lung-larynx, breast-endometrium, and breast-colon. The history of smoking and alcohol was found to be higher in male patients andsynchronous tumors.CONCLUSION: The detection of the first tumor in the metastatic stage and an accompanying synchronous secondary tumor was found to be a poor prognostic factor. The treatment of the first tumor, smoking, squamous cell histology, and male gender were among the other factors negatively affecting survival,although they were not statistically significant.

🔖

Bu Makaleye Atıf Yap

GOKYER, A., UZUNOGLU, S., HACİOGLU, M. B., ERDOGAN, B., CİCİN, I., HACİBEKİROGLU, I., TURKMEN, E., KODAZ, H., KOSTEK, O. (2022). Clinical features of the patient with multiple primary tumors: Single center experience. İstanbul Kuzey Klinikleri, Cilt: 4 - Sayı: 1, 43–51. https://ajindex.com/articles/551582

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Tachimori Y. Cancer screening in patients with cancer. Jpn J Clin Oncol 2002;32:118-9
  2. Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol 2003;26:79-83
  3. Suzuki T, Takahashi H, Yao K, Inagi K, Nakayama M, Makoshi T, et al. Multiple primary malignancies in the head and neck: a clinical review of 121 patients. Acta Otolaryngol Suppl 2002;88-92
  4. Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol 2010;20:67-78
  5. Hemminki K, Boffetta P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 2004;289-97
  6. Carey TE. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann Med 1996;28:183-8
  7. Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 1977;40:1872-8
  8. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932;16:1358-414
  9. Haddow AJ, Boyd JF, Graham AC. Multiple primary neoplasms in the Western Hospital Region, Scotland: a survey based on cancer registration data. Scott Med J 1972;17:143-52
  10. Storm HH, Jensen OM, Ewertz M, Lynge E, Olsen JH, Schou G, et al. Summary: multiple primary cancers in Denmark, 1943- 80. Natl Cancer Inst Monogr 1985;68:411-30
  11. Aydiner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms. Am J Clin Oncol 2000;23:364-70
  12. Leon ME, Peruga A, McNeill A, Kralikova E, Guha N, Minozzi S, et al. European Code against Cancer, 4th Edition: Tobacco and cancer. Cancer Epidemiol 2015;39 Suppl 1:S20-33
  13. Williams LA, Olshan AF, Tse CK, Bell ME, Troester MA. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study. Cancer Causes Control 2016;27:259-69
  14. Li F, Zhong WZ, Niu FY, Zhao N, Yang JJ, Yan HH, et al. Multiple primary malignancies involving lung cancer. BMC Cancer 2015;15:696
  15. Irimie A, Achimas-Cadariu P, Burz C, Puscas E. Multiple primary malignancies--epidemiological analysis at a single tertiary institution. J Gastrointestin Liver Dis 2010;19:69-73